Pasi A Jänne, MD, Director, Lowe Center for Thoracic Oncology, Belfer Center for Applied Cancer Science, Senior Physician, Professor of Medicine at Harvard Medical School decides on whether the results of the RELAY trial will impact the management of 1st line EGFR non-small cell lung cancer (NSCLC).
